Literature DB >> 7948140

Active immunization of metastatic melanoma patients with interleukin-4 transduced, allogeneic melanoma cells. A phase I-II study.

N Cascinelli1, R Foà, G Parmiani, F Arienti, F Belli, M G Bernengo, C Clemente, M P Colombo, A Guarini, M T Illeni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7948140     DOI： 10.1089/hum.1994.5.8-1059

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  5 in total

Review 1.  Immunotherapy I: Cyclosine gene transfer strategies.

Authors:  M P Colombo; G Forni
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 2.  Gene therapy for cancer, the course ahead.

Authors:  R G Vile
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 3.  Gene therapy. Clinical potential and relationship to drug treatment.

Authors:  K A Whartenby; A J Marrogi; S M Freeman
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546

Review 4.  Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials?

Authors:  M P Colombo; M Rodolfo
Journal:  Cancer Immunol Immunother       Date:  1995-11       Impact factor: 6.968

Review 5.  Vaccination for melanoma.

Authors:  L W Thompson; L Brinckerhoff; C L Slingluff
Journal:  Curr Oncol Rep       Date:  2000-07       Impact factor: 5.945
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.